Changes in markers of inflammation and their correlation with death in patients with COVID-19 in the intensive care unit
AAP Weber, FT Viero, MM Pillat, T de Lima Gonçalves - Cytokine, 2024 - Elsevier
This study aimed to characterize the changes in serum inflammatory mediators in
hospitalized patients with COVID-19 correlating with death. The study includes 58 …
hospitalized patients with COVID-19 correlating with death. The study includes 58 …
[HTML][HTML] Inflammatory and Prothrombotic Biomarkers Contribute to the Persistence of Sequelae in Recovered COVID-19 Patients
N Garcia-Larragoiti, A Cano-Mendez… - International Journal of …, 2023 - mdpi.com
The presence of long COVID (LC) following SARS-CoV-2 infection is a common condition
that affects the quality of life of patients and represents a diagnostic challenge due to the …
that affects the quality of life of patients and represents a diagnostic challenge due to the …
[HTML][HTML] Calprotectin and imbalances between acute-phase mediators are associated with critical illness in COVID-19
G Kassianidis, A Siampanos, G Poulakou… - International Journal of …, 2022 - mdpi.com
The trajectory from moderate and severe COVID-19 into acute respiratory distress syndrome
(ARDS) necessitating mechanical ventilation (MV) is a field of active research. We …
(ARDS) necessitating mechanical ventilation (MV) is a field of active research. We …
[HTML][HTML] Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs …
AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
[PDF][PDF] Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
Y Liu, C Zhang, F Huang, Y Yang, F Wang… - National Science …, 2020 - academic.oup.com
A recent outbreak of pneumonia in Wuhan, China was found to be caused by a 2019 novel
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …
[HTML][HTML] High levels of circulating IL-8 and soluble IL-2R are associated with prolonged illness in patients with severe COVID-19
A Ma, L Zhang, X Ye, J Chen, J Yu, L Zhuang… - Frontiers in …, 2021 - frontiersin.org
Objectives The coordinated immune response of the host is the key of the successful combat
of the body against SARS-CoV-2 infection and is decisive for the development and …
of the body against SARS-CoV-2 infection and is decisive for the development and …
Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
M Ghaebi, S Tahmasebi, M Jozghorbani, A Sadeghi… - Life sciences, 2021 - Elsevier
Abstract Severe coronavirus disease 2019 (COVID-19) caused by the Severe Acute
Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is characterized by an unpredictable …
Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is characterized by an unpredictable …
[HTML][HTML] Severe COVID-19 and sepsis: immune pathogenesis and laboratory markers
The ongoing outbreak of the novel coronavirus disease 2019 (COVID-19), induced by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has taken a significant toll …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has taken a significant toll …
[HTML][HTML] Serum biomarkers associated with SARS-CoV-2 severity
F de Morais Batista, MAM Puga, PV da Silva… - Scientific Reports, 2022 - nature.com
Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well
understood to differentiate mild from severe cases and identify prognostic markers. We …
understood to differentiate mild from severe cases and identify prognostic markers. We …
[HTML][HTML] SARS-CoV-2-specific immune response and the pathogenesis of COVID-19
E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …